Diabetic Cohort

This prospective cohort consists of 14,355 adult patients with type 2 diabetes who were recruited from various polyclinics and restructured hospitals in the period 2004 to 2010.

 Interview data  Medical records data  Physical examination  Laboratory tests
  • Socio-demographic characteristics
  • Tobacco use
  • Medical history
  • History of diabetes complications
  • Family history
  • Diabetes profile and treatment
  • Blood pressure profile and treatment
  • Lipid profile and treatment
  • Complications of kidney, eye and macrovascular systems
  • Height, weight, hip and waist circumferences
  • Urine protein, glucose, ketone and blood (semi-quantitative)
  • C-reactive protein (hsCRP)
  • Cortisol

Consent form
Data collection form

Revisit of the Diabetic Cohort

410 participants of the Diabetic Cohort were selected for a pilot follow-up in 2010 to study associations between the glycaemic index of their diet with glycaemic control and risk factors for cardiovascular disease.

Following the pilot, in 2012, the Diabetic Cohort participants were followed up using the same recruitment and data collection protocol as the Revisit of the Multiethnic Cohort. The follow-up ended in 2016 with a total of 2608 participants revisited since 2012.

 Interview data  Physical examination  Laboratory tests
  • Socio-demographic characteristics
  • Tobacco use
  • Environmental tobacco smoke
  • Alcohol consumption
  • Diet (FFQ and * 24hr recall)
  • Physical activity
  • Medication use
  • Medical history
  • Women’s health
  • Family history
  • * Health care expenditure
  • Health-related Quality of Life (SF-12/SF-36 and EQ-5D)
  • Stress
  • Kessler Psychological Distress Scale (K10)
  • Cognitive test (MMSE)
  • Height, weight, hip and waist circumferences
  • Blood pressure
  • Central aortic blood pressure
  • Ankle Brachial Index
  • Skinfold thickness
  • Resting electrocardiogram
  • Assessment of foot sensory function by monofilament and neurothesiometer
  • Hand grip strength
  • Serum creatinine
  • Fasting glucose
  • Blood lipids
  • HbA1c
  • Urine albumin (semi-quantitative)
  • C-reactive protein (hsCRP)
  • Cortisol
  • Interleukin-6
  • Interleukin-1 receptor antagonist

* Administered only in the pilot study.

Consent form
Data collection form
Consent form used only in pilot study
Data collection form used only in pilot study

Back to top ↑

Last updated on 21 June 2017